drug side effects

News

Scientists have made progress in the quest to find medication for Type 2 diabetes that causes fewer side effects than current treatments.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.